An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.
Experimental Drug Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also obtaining discount codes.
Thriving Commerce on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for purchases.
Understanding The Experimental Drug
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Voice Worries
However, doctors and chemists have warned that the distribution of what remains an unlicensed medication in the UK is worrisome and could lead to users injecting substances of uncertain source.
Some professionals said the popularity for the experimental drug could be linked to the increasing cost of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate pharmaceutical, advertising, and consumer laws, potentially leading to fines, legal action or prison.
Service Reaction and Content Elimination
Based on the social media company, the service has taken down violative material and banned related keywords and search suggestions. The organization said it was dedicated to maintaining the platform secure and allocating resources in enhancing enforcement strategies.
Online Trading Activities
Research also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays channels with thousands of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for preparing or injecting at home.
After minutes of entering one community, a vendor posted WhatsApp details, where most purchases occur. The seller provided an guidebook and guaranteed delivery within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, health issues or past usage.
Product Information and Pricing
Within these groups, messages show dark colored packages with Royal Mail labels, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically priced at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram stated it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting materials they cannot confirm. Even if the science behind retatrutide is valid, these online products may not contain what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has previously seen patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject users to potentially serious medical dangers”.
